Exactech Appoints New Chief Financial Officer

Exactech, a developer and producer of innovative implants, instrumentation and computer-assisted technologies for joint replacement surgery, has announced Kerem Bolukbasi as its new chief financial officer (CFO). Bolukbasi joins Exactech from TPG Capital where he...

Philips launches Rapid Equipment Deployment Kit to COVID-19 response

Royal Philips has introduced its Rapid Equipment Deployment Kit for ICU ramp-ups, allowing doctors, nurses, technicians and hospital staff to quickly support critical care patient monitoring capabilities during the COVID-19 pandemic. Currently successfully in use in...

Pure Processing Hires New CFO

Pure Processing LLC, developer and provider of pre-cleaning stations, technologies and accessories for health care reprocessing departments, has announced the appointment of Carrie Pasinski, an experienced finance and operations leader, as chief financial officer for...

Delay in breast cancer operations due to COVID-19 pandemic appears to be non-life-threatening for women with early-stage disease

Results of Journal of the American College of Surgeons study should reassure breast cancer patients who experienced surgical postponements due to COVID-19 pandemic A new breast cancer study brings reassuring findings for women with early-stage breast cancer who were...

Smart Tattoo Sensors and Continuous Vital Signs Monitoring

The measurement of vital signs is critical for medical professionals to be able to assess the general health of patients and detect any possible health deterioration as early as possible. However, standard holster devices are bulky and uncomfortable for the patient while providing only a snapshot of limited information during the brief time they are worn.

Umana T1 is a new clinical grade solution which addresses these challenges directly by using tattoo sensors made from an almost imperceptible clear film with conductive sensors. Having launched an independent clinical trial with 2,000 patients at the national hospital in Malta and working on collaborative projects in Portugal and the United Kingdom, the Umana T1 Heart Monitor will be launched across Europe in May 2018.

Commenting on this innovation, Dr. Samuel Meilak, who is coordinating the trial, notes that “our cardiology staff is excited about what the Umana T1 means for our profession and our patients. Finally, we are able to accurately collect and monitor patients’ important medical data without interfering with their day-to-day activities. The ease of access, coupled with the data analysis capabilities are complete game changers.”

Once the tattoo is applied, a small lightweight device is attached to store and share a stream of accurate real-time vital signs such as ECG data as well other vital parameters such as respiration rate. These are than shared directly with a trusted medical professional. This user-friendly setup is completed with an ecosystem of medical software, a smartphone application, online dashboards, data-analysis algorithms, online and offline data access.

Umana Co-Founder and CEO Dr. Adrian Attard Trevisan elaborates: “The tattoo sensors represent a giant leap forward for how vital signs can be continuously monitored but we went even further, with comprehensive digital data storage and processing infrastructure to allow medical professionals to get an unprecedented in-depth view and analysis of the patient’s status.”

Key members of the Umana team will be attending the HIMSS Conference in Barcelona in late May. The team will also be discussing the ways in which implementation of Umana T1 ensures better quality patient care and will be exploring potential research collaborations in further developing non-invasive methods for collecting, monitoring and analyzing long-term vital parameters.



Submit a Comment

Your email address will not be published. Required fields are marked *